综述 Review

过氧化物酶体增殖剂激活受体γ的结构特征和生物学功能

  • 张文旭 ,
  • 李文立
展开
  • 青岛农业大学动物科技学院, 青岛 266109
张文旭(1987-),女,山东济南人,硕士研究生,从事单胃动物营养与饲料科学研究。E-mail:zhangwx1001@163.com

收稿日期: 2012-03-22

  网络出版日期: 2012-09-03

Peroxisome Proliferators Activated Receptor Gamma: Structure Feather and Biological Function

  • ZHANG Wenxu ,
  • LI Wenli
Expand
  • College of Animal Science and Technology, Qingdao Agricultural University, Qingdao 266109, China

Received date: 2012-03-22

  Online published: 2012-09-03

摘要

过氧化物酶体增殖剂激活受体γ(PPARγ)是核激素受体超家族转录因子成员之一,在机体能量代谢、细胞分化、神经损伤、炎性反应及心脑血管疾病中发挥重要的调控作用。本文就PPARγ及其配体的结构特征和生物学功能作了简要介绍。

本文引用格式

张文旭 , 李文立 . 过氧化物酶体增殖剂激活受体γ的结构特征和生物学功能[J]. 动物营养学报, 2012 , 24(9) : 1628 -1635 . DOI: 10.3969/j.issn.1006-267x.2012.09.003

Abstract

Peroxisome proliferators activated receptor γ (PPARγ) is a kind of nuclear transcription factor which belongs to the nuclear hormone receptor superfamily. It can play important regulatory roles in energy metabolism, cell differentiation, nerve injury, inflammatory reaction, cardiac cerebral and vascular diseases. This paper reviewed the structure feather and biological function of PPARγ and its ligand.

参考文献

[1] ISSEMANN I,GREEN S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators[J].Nature,1990,347:645-650.
[2] 罗锦标,田勇,陶争荣.PPAR基因在鹅肥肝形成中的可调节性表达[J].中国农业科学,2008,41(10):3270-3276.
[3] 朱凌燕,刘建英.PPARγ基因研究进展[J].江西医药,2011,46(6):572-574.
[4] 王博,吴江维,杨公社.PPAR-γ在八眉猪不同组织中的表达差异[J].畜牧兽医学报,2008,39(3):273-277.
[5] 张乾勇.PPAR的结构与功能及其生物学作用[J],国外医学卫生学分册,2000,27(5):284-287.
[6] DEPLANQUE D,GELE P,PETRAULT O,et al.Peroxisome proliferators activated receptorαactivation as a mechanism of preventive neural protection induced by chronic fenofibrate treatment[J].Neuroscience,2003,23:6264-6271.
[7] AKUNE T,OHHA S,KAMEKURA S,et al.PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors[J].Journal of Clinical Investigation,2004,113:846-855.
[8] 林晓萍,刘洪利,杜莉莉.PPARγ激动剂对T细胞增殖及破骨细胞形成的影响[J].上海口腔医学,2011,20(4):347-351.
[9] LECKA-CZERNIK B.Bone as a target of type 2 diabetes treatment[J].Current Opinion in Investigation Drugs,2009,10(10):1085-1090.
[10] JENNINGS J S,GERBER A M,VALLANO M L.Pharmacological strategies for neuroprotection in traumatic brain injury[J].Mini-Reviews in Medicinal Chemistry,2008,8(7):689-701.
[11] 乔保华,高建新,王芬,等.PPARγ激动剂吡格列酮减少大鼠创伤性脑损伤后的神经损伤和胶质增殖[J].中国病理生理杂志,2010,26(5):912-916.
[12] HYONG A,JADHAV V,LEE S,et al.Rosiglitazone,a PPAR gamma agonist,attenuates inflammation after surgical brain injury in rodents[J].Brain Research,2008,1215:218-224.
[13] STEINMAN L,MARTIN R,BERNARD C,et al.Multiple sclerosis:deeper understanding of its pathogenesis reveals new targets for therapy[J].Annual Reviews:Neuroscince,2002,25:491-505.
[14] SCHUTZ B,REIMANN J,DUMITRESCU-OZIMEK L,et al.The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase G93A transgenicmice mice[J].Neuroscience,2005,25(34):7805-7812.
[15] NICOLAKAKIS N,ABOULKASSIM T,ONGALI B,et al.Complete rescue of cerebrovascular function in aged Alzheimer’s disease transgenic mice by antioxidants and pioglitazone,a peroxisome proliferator-activated receptor γ agonist[J].The Journal of Neuroscience,2008,28(37):9287-9296.
[16] BREIDERT T,CALLEBERT J,HENEKA M T,et al.Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson’s disease[J].Neurochemistry,2002,82(3):615-624.
[17] 裴红红,张正良,白郑海,等.大鼠自体原位肝移植胆道缺血再灌注损伤胆道组织PPARγ mRNA表达的意义[J].陕西医学杂志,2011,40(2):141-144.
[18] 狄政莉,田晔,马红兵,等.缺氧/复氧损伤对大鼠海马神经元过氧化物酶体增殖物激活受体γ表达的影响[J].中南大学学报:医学版,2009,34(12):1238-1242.
[19] 刘尊敬,杨期东,刘运海.PPARγ激活剂对大鼠缺血再灌注脑组织的保护作用及对PPARγ表达的影响[J].中风与神经疾病杂志,2007,124(2):132-135.
[20] PARK S W,YI J H,MIRANPURI G,et al.Thiazolidinedione class of peroxisome proliferators-activated receptor-gamma agonists prevents neuronal damage,motor dysfunction,myelin loss,neuropathic pain and inflammation after spinal cord injury in adult rats[J].Pharmacology and Experimental Therapeutics,2007,320(3):1002-1012.
[21] 李强,党诚学.胃癌组织中PPARγ的表达[J].山东医药,2011,51(34):13-14.
[22] 李慧艳,谢贤和,侯梅.PPARγ在结直肠癌中的表达及临床意义[J].海南医学,2011,22(12):12-14.
[23] 陈家炜,任跃忠.PPARγ对人胰腺癌细胞中抑癌基因PTEN表达的影响[J].细胞与分子免疫学杂志,2010,26(8):828-829.
[24] FARROW B,O’CONNOR K L,HASHIMOTO K,et al.Selective activation of PPAR gamma inhibits pancreatic cancer invasion and decreases expression of tissue plasminogen activator[J].Surgery,2003,134(2):206-208.
[25] 康敏,钟德君,李昌平.PPARγ的配体罗格列酮诱导肝癌细胞凋亡的实验研究[J].现代预防医学,2009,36(7):1352-1357.
[26] 陆谔梅,叶劲军,黄健.PPARγp27在宫颈癌组织中的表达及其临床意义[J].临床肿瘤学杂志,2011,16(5):433-436.
[27] 陈彦平,杨凯成,梁玉林.PPARγPCNA在口腔鳞癌组织的表达及临床意义[J].第三军医大学学报,2011,33(16):1718-1720.
[28] TAKASHIMA T,FUJIWARA Y,HIGUCHI K,et al.PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis,cell cycle arrest and reduction of ornithine decarboxylase activity[J].International Journal of Oncology,2001,19(3):465-467.
[29] KONTUREK P C,KANIA J,KUKHARSKY V,et al.Implication of peroxisome proliferator-activated receptor gamma and proinflammatory cytokines in gastric carcinogenesis:link to helicobacter pylori-infection[J].Pharmacological Sciences,2004,96(2):134-136.
[30] INOUE K,KAWAHITO Y,SANO H.Peroxisome proliferator-activated receptor-gamma expression in lung[J].Chest,2002,122(1):386-387.
[31] 张洪斌,高鹏飞,赫海涛.乳腺癌组织中PPARγ的表达及其预后意义[J].现代预防医学,2011,38(23):4848-4849.
[32] 杨崇志,张会堂,王公升,等.PPARγ激动剂对成人正常皮肤成纤维细胞转分化的作用[J].中国美容医学,2010,19(7):1006-1008.
[33] 刘宏旭,周睿,姜学东,等.PPARγ配体抑制气道肌纤维母细胞分化的作用机制[J].中国医科大学学报,2010,39(7):511-514.
[34] LEE Y R,YU H N,NOH E M,et al.Peroxisome proliferator-activated receptor gamma and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells[J].International Journal of Hematology,2007,85(3):231-237.
[35] INOUE S,SNOWDEN R T,DYER M J,et al.CDDO induces apoptosisvia the intrinsic pathway in lymphoid cells[J].Leukemia,2004,18:948-952.
[36] LAPSYS N M,KRIKETOS A D,LIM-FRASER M,et al.Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor gamma expression in human skeletal muscle[J].Journal of Clinical Endocrinology and Metabolism,2000,85(11):4293-4297.
[37] 苏胜彦,李齐发,刘振山.朗德鹅填饲后不同组织PPARγ基因mRNA表达量差异的初步研究[J].畜牧兽医学报,2008,39(7):879-881.
[38] IMAI T,TAKAKUWA R,MARCHAND S,et al.Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse[J].Proceedings of the National Academy of Sciences 2004,101:4543-4547.
[39] ROSEN E D,SARRAF P,TROY A E,et al.PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro[J].Molecular Cell,1999,4(4):611-617.
[40] 姜俊芳.脂肪细胞分化相关因子基因表达在猪生长过程中的变化规律研究.博士学位论文.杭州:浙江大学,2006:76-80.
[41] 邵根宝,贾超,刘红林.与PPAR基因连锁的5个微卫星标记与猪肉质性状的相关性[J].农业生物技术学报,2006,14(2):162-165.
[42] 崔景香.猪肌内脂肪沉积相关基因的mRNA表达及功能分析.博士学位论文.泰安:山东农业大学,2011:68-73.
[43] 陈哲,郭晓令,徐宁迎.PPARγ2基因外显子1多态性与猪背膘厚性状的相关性分析 //刘红林.第十二次全国畜禽遗传标记研讨会论文集.:The Regional Coordinating Centre,ANBAPH,2010,12(1):57-59.
[44] VALVERDE A M,BENITO M,LORENZO M.The brown adipose cell:a model for understanding the molecular mechanisms of insulin resistance[J].Acta Physiologica Scandinavica,2005,183(1):59-73.
[45] LAZAR M A.PPAR gamma,10 years later[J].Biochemistry and Molecular Biology,2005,87(1):9-13.
[46] COCK T A,HOUTEN S M,AUWERX J.Peroxisome proliferator-activated receptor-gamma:too much of a good thing causes harm[J].European Molecular Biology Organization:Reports,2004,5(2):142-147.
[47] SEMPLE R K,CHATTERJEE V K,RAHILLY S O.PPARγ and human metabolic disease[J].Journal of Clinical Investigation,2006,116(3):581-589.
[48] YOSHIOKA S,NISHINO H,SHIRAKI T,et al.Antihy pertensive effects of CS-045 treat-ment in obese Zucker rats[J].Metabolism,1993,42:75-80.
[49] 孔俭,孙建,汲宏垒.罗格列酮对自发性高血压大鼠的降压作用[J].高血压杂志,2003,11(5):454-456.
[50] TONTONOZ P,NAGY L,ALVAREZ J G A,et al.PPAR gamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL[J].Cell,1998,93(2):241-252.
[51] CHAWLA A,BOISVERT W A,LEE C H,et al.A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis[J].Molecular Cell,2001,7(1):161-171.
[52] 高鹏,杜丹华,吴江.PPARγ基因多态性与动脉粥样硬化性脑梗死的相关性研究[J].中风与神经疾病杂志,2009,26(2):28-31.
[53] CUZZOCREA S,PISANO B,DUGO L,et al.Rosiglitazone a ligand of the peroxisome proliferator-activated receptor-gamma,reduces the development of nonseptic shock induced by zymosan in mice[J].Critical Care Medicine,2004,32(2):457-466.
[54] 乔万海,屈莉,古长维.PPARγ对多器官功能障碍综合征大鼠炎性反应的影响[J].临床急诊杂志,2010,11(3):151-153.
[55] 赵晓媛,史红,魏超,等.PPARγ参与吡格列酮的镇痛作用[J].中国新药杂志,2010,19(3):229-235.
[56] 孔路军.过氧化物酶体增殖物活化受体对母猪繁殖性能的影响研究.博士学位论文.北京:中国农业大学,2006:91-99.
[57] 鲁晶.PPARγ激活对脂多糖刺激仔猪免疫应激的调节作用.硕士学位论文.武汉:武汉工业学院,2008:19-21.
[58] NAKANO R,KUROSAKI E,SHIMAYA A,et al.YM440,a novel hypoglycemic agent,protects against nephropathy in Zucker fatty rats via plasma triglyceride reduction[J].European Journal of Pharmacology,2006,549(1/2/3):185-191.
[59] SOMMER M,WOLF G.Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide[J].American Journal of Nephrology,2007,27(4):425-434.
[60] YAO Y,ZOU R,LIU X,et al.Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma[J].Journal of Huazhong University of Science and Technology:Medical Sciences,2008,28(5):543-548.
[61] YOUSEFIPOUR Z,HERCULE H,OYEKAN A O,et al.Antioxidant U74389G improves glycerol-induced acute renal failure without affecting PPARgamma gene[J].Renal Failure,2007,29(7):903-910.
文章导航

/